Table 2.
Patient Characteristics | Odds Ratio | 95% LCLa | 95% UCLb | Adjusted P-Valuec |
---|---|---|---|---|
Age Group (Ref: 25–34) | ||||
35–44 | 0.794 | 0.219 | 2.873 | 1.000 |
45–54 | 0.623 | 0.174 | 2.236 | 1.000 |
Race Quintile (Ref: Quintile 1) | ||||
2 | 1.111 | 0.305 | 4.054 | 1.000 |
3 | 2.298 | 0.670 | 7.884 | 1.000 |
4 | 3.175 | 0.939 | 10.729 | 0.090 |
5 | 4.380 | 1.304 | 14.708 | 0.003 |
Age Group & Race Quintile Interaction (Ref: Age Group=1, Race Quintile=1)d | ||||
2#2 | 1.126 | 0.283 | 4.476 | 1.000 |
2#3 | 0.638 | 0.171 | 2.378 | 1.000 |
2#4 | 0.515 | 0.140 | 1.888 | 1.000 |
2#5 | 0.519 | 0.143 | 1.893 | 1.000 |
3#2 | 1.164 | 0.296 | 4.582 | 1.000 |
3#3 | 0.594 | 0.161 | 2.196 | 1.000 |
3#4 | 0.468 | 0.129 | 1.702 | 1.000 |
3#5 | 0.409 | 0.113 | 1.480 | 1.000 |
Health Plan Type (Ref: Comprehensive) | ||||
EPO | 1.158 | 0.842 | 1.592 | 1.000 |
HMO | 1.213 | 1.054 | 1.396 | <0.001 |
POS | 1.047 | 0.904 | 1.213 | 1.000 |
PPO | 1.024 | 0.896 | 1.170 | 1.000 |
CDHP/HDHP | 0.936 | 0.761 | 1.151 | 1.000 |
Geographic Regions (Ref: Northeast) | ||||
Midwest | 0.643 | 0.584 | 0.709 | <0.001 |
South | 0.557 | 0.509 | 0.609 | <0.001 |
West | 0.601 | 0.543 | 0.666 | <0.001 |
Comorbidity Status (Ref: CCI=0) | ||||
CCI=1 | 0.957 | 0.882 | 1.038 | 1.000 |
CCI>1 | 0.770 | 0.672 | 0.882 | <0.001 |
Income Quintile (Ref: Quintile 1) | ||||
2 | 0.927 | 0.819 | 1.048 | 1.000 |
3 | 1.106 | 0.982 | 1.245 | 0.265 |
4 | 1.139 | 1.012 | 1.282 | 0.015 |
5 | 1.442 | 1.274 | 1.631 | <0.001 |
Education Quintile (Ref: Quintile 1) | ||||
2 | 0.887 | 0.758 | 1.038 | 0.607 |
3 | 1.013 | 0.870 | 1.180 | 1.000 |
4 | 1.064 | 0.913 | 1.239 | 1.000 |
5 | 1.292 | 1.104 | 1.511 | <0.001 |
Baseline Uterine Leiomyoma-related Conditions | ||||
Menstrual Disorders | 1.506 | 1.425 | 1.592 | <0.001 |
Pelvic Pain | 0.772 | 0.726 | 0.820 | <0.001 |
Anemia | 1.267 | 1.188 | 1.352 | <0.001 |
Constipation or Gas | 1.054 | 0.899 | 1.235 | 1.000 |
Urinary Problems | 0.975 | 0.839 | 1.133 | 1.000 |
Baseline Other Gynecologic Conditions | ||||
Endometriosis | 0.560 | 0.483 | 0.651 | <0.001 |
Disorders of Uterus (unclassified) | 1.002 | 0.932 | 1.078 | 1.000 |
Genital Prolapse | 0.237 | 0.181 | 0.309 | <0.001 |
Benign Neoplasm of the Uterus or Ovary | 0.705 | 0.445 | 1.116 | 0.613 |
Infertility | 5.657 | 4.516 | 7.085 | <0.001 |
Baseline Non-gynecologic Conditions | ||||
Inflamatory Disease | 1.207 | 1.116 | 1.304 | <0.001 |
Noninflamatory Disease | 0.921 | 0.859 | 0.988 | 0.006 |
Any Inpatient Admission | 0.779 | 0.686 | 0.885 | <0.001 |
Any Emergency Room Admission | 0.927 | 0.868 | 0.990 | 0.007 |
Any NSAID Use | 0.982 | 0.925 | 1.043 | 1.000 |
Any Hormone Use | 1.139 | 1.078 | 1.204 | <0.001 |
Constant | 0.229 | 0.067 | 0.778 | 0.004 |
Notes:
LCL=Bonferroni-corrected Lower Confidence Limit.
UCL= Bonferroni-corrected Upper Confidence Limit. Bold-faced numbers indicates statistical significance with p-value<0.05.
Adjusted p-values are based on Bonferroni correction.
Age Groups: 1:18–34; 2:35–44; 3:45–54; 2#2 means interaction of age group 2 and race quintile 2, and so on.